Perception of risk from tobacco use is lower among cancer survivors who smoke
the ONA take:
A new study identified several factors that inhibit the efforts of cancer survivors who smoke to quit. In the study, cancer survivors who smoke reported fewer negative opinions about smoking, have more barriers to quitting, and are around other smokers more often than survivors who quit before or after their diagnosis.
The researchers report that patients with cancers strongly linked to smoking, such as lung and head and neck, had high initial quit rates; however, many relapse and begin smoking again. Quit rates are not high among patients with other cancers. Researchers feel they may not realize the connection between their cancer and smoking, or they did not receive advice or follow-up assistance in regard to smoking cessation.
The analysis also revealed that survivors who currently smoked reported more daily exposure to others who smoke. The researchers say this is a factor that needs to be considered when counseling patients about quitting smoking. They suggest that exposure to other smokers should be addressed when counseling patients with cancer to quit.
A new study identified several factors that inhibit the efforts of cancer survivors who smoke to quit.
Sign Up for Free e-newsletters
- Managing Chemo Brain in Pediatric Survivors of Childhood Cancer
- Aggressive Therapy Provides No Additional Advantage in Metastatic Prostate Cancer
- Excretion of Volatile Organic Compounds Higher in AYAs Using Vaping Products
- FDA, ASHP Actions to Prevent or Manage Chemotherapy Drug Shortages
- Breast Cancer Screening Recommendations Not Completely Reflective of Race, Age
- Various Aspects of Palliative Care Focus Associated With Different Outcomes In Cancer
- Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
- Patient Expectations at Odds With Actual Outcomes for Radiotherapy in Breast Cancer
- Patients Desire More Online Tools and Access
- Metformin Plus Ruxolitinib: A Potential Therapeutic Alternative for Myeloproliferative Neoplasms
- Sexual Quality of Life Decreased During, After Chemotherapy for Digestive Cancers
- CHEMO-SUPPORT: A Nursing Intervention to Relieve Chemotherapy Symptom Burden
- Approach and Management of Checkpoint Inhibitor-related Immune Hepatitis
- Revised AJCC8 Demonstrates Superior Tumor Classification for HNCSCC
- Oral Androgen Receptor Inhibitor Granted FDA Approval for Nonmetastatic CRPC
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|